Search results
GoodRx Holdings, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law...
Morningstar· 2 days agoNEW YORK, June 20, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of GoodRx Holdings, Inc. (NASDAQ: GDRX). Shareholders who purchased shares of GDRX during the class period listed are
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of...
Morningstar· 1 day agoFaruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ: GDRX) and reminds investors ...
GDRX Investors Have Opportunity to Lead GoodRx Holdings, Inc. Securities Fraud Lawsuit
Morningstar· 4 days agoBENSALEM, Pa., June 18, 2024 /PRNewswire/ -- Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against GoodRx Holdings, Inc. ("GoodRx" or the "Company")
Need a cut? Here’s a look at the history of lawn mowers
WKMG ClickOrlando· 6 days agoThe history of the lawn mower is really the history of cutting grass, and that starts with a scythe....
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit...
Morningstar· 2 days agoThe Law Offices of Frank R. Cruz reminds investors of the upcoming June 21, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired GoodRx ...
Weight-loss-drug frenzy lures rich Indians to brave the gray market - Indianapolis Business Journal
Indianapolis Business Journal· 1 day agoThe race to score blockbuster weight-loss drugs is pushing one of the world’s largest population of...
Abortion is becoming more common in primary care clinics as doctors challenge stigma
KTEP 88.5 El Paso· 2 days agoIt’s a typical Tuesday at Seven Hills Family Medicine in Richmond, Va. The team — which consists of...
India's gray market is selling Wegovy at less than 10% of U.S. prices—even though weight-loss drugs...
Fortune· 3 days agoSuch is the interest that the anti-obesity medication market could reach $100 billion by 2030, Goldman Sachs Research said. Indians, meanwhile, have simply been watching this from the sidelines ...